Salzman
Salzman v. ImmunityBio, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 ZACHARY SALZMAN, Individually and Case No.: 23-cv-01216-GPC-WVG on Behalf of All Others Similarly 12 Situated, ORDER APPOINTING LEAD PLAINTIFF AND APPROVING Plaintiff,
LEAD PLAINTIFF’S SELECTION
14 v. OF COUNSEL
IMMUNITYBIO, INC., RICHARD
[ECF Nos. 17–18] ADCOCK, DAVID C. SACHS, and
PATRICK SOON-SHIONG,
17 Defendant.
19 Pending before the Court is the matter of appointing lead plaintiff in this putative 20 securities fraud class action brought on behalf “of all persons and entities other than 21 Defendants that purchased or otherwise acquired ImmunityBio securities between May 22 23, 2022 and May 10, 2023 . . . .” ECF No. 1 at 2. On August 29, 2023, movants Dipak 23 T. Patel (“Patel”), Yuchang Chen (“Chen”), Timothy L. Van Eman (“Eman”), and 24
26 1 Page citations refer to CM/ECF pagination. 27 Mitchell Brock (“Brock”), each filed a motion to be appointed lead plaintiff pursuant to 15 U.S.C. §78u-4(a)(3). ECF Nos. 15–18. …